Patients with heart failure and iron deficiency treated with intravenous iron had lower rates of cardiovascular death or hospitalization for heart failure, but results of the FAIR-HF2 study failed ...

After the positive findings of the FAIR-HF trial, there is a need for cardiologists to study the iron metabolism of patients with CHF, and it seems reasonable to undertake a work-up evaluation if ...

Iron-deficiency anemia is also hard on your heart. When your organs don't get enough oxygen, your heart has to pump even harder to push out more blood. That extra work can damage your heart muscle.

Weakness, fatigue, and difficulty in focusing are all common symptoms of being iron deficient—and according to a new study ...

More information: Stefan D. Anker et al, Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency, Nature Medicine (2025). DOI: 10.1038 ...

Learn more about how this delicious green drink can block your body from absorbing iron and what you can do to avoid it ...

Heart failure impacts millions of people worldwide, causing multiple hospital stays and life quality deterioration. The presence of iron deficiency among 49% of these patients remains unclear to ...

Even among adults without conditions that may be associated with iron deficiency – anemia, heart failure, chronic kidney disease or pregnancy – the estimated prevalence of absolute iron ...

Iron deficiency may affect more than 1 in 6 adults in the U.S., ... shortness of breath, confusion, heart failure, irregular heartbeats and death. But iron deficiency does not just cause anemia.

Iron deficiency in pregnancy linked to heart disease in newborns in ‘gamechanger’ discovery This is the first time anaemia in the early stages of pregnancy has been identified as an issue. 2 ...

Postpartum women are also at risk of iron deficiency, said Dr. Johanna Contreras, an advanced heart failure and transplant cardiologist at the Mount Sinai Fuster Heart Hospital in New York City.

Anker will present the study, “Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure (FAIR-HF2) Trial,” on Sunday, March 30 ...